Anicom Holdings (8715) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jul, 2026Executive summary
Recurring revenue rose 11.1% year-over-year to ¥16,519 million, driven by robust demand for pet insurance and operational efficiency improvements.
Recurring profit before amortization of goodwill increased 34.3% year-over-year to ¥1,682 million; recurring profit was ¥1,620 million, up 34.8%.
Profit attributable to owners of parent rose 37.0% to ¥1,111 million.
Number of new policies for Apr–Jun was 57,000, with policies in force totaling 1,213,737 (+7.1% YoY).
The company is accelerating initiatives in genetic testing, animal health checks, and advanced veterinary medicine to expand its prevention-focused business model.
Financial highlights
Underwriting revenue grew 7.7% year-over-year to ¥14,351 million; investment revenue surged 134.3% to ¥295 million.
Other recurring revenue increased 32.3% to ¥1,871 million.
Net profit for the quarter was ¥1,098 million, up from ¥811 million a year earlier.
Net claims paid increased 9.5% to ¥8,045 million; operating and general administrative expenses rose 6.8% to ¥4,183 million.
Basic earnings per share increased to 13.98 yen from 9.99 yen year-over-year.
Outlook and guidance
Full-year forecast for FY2025 projects recurring revenue of ¥66,000 million (+9.2% YoY), recurring profit of ¥4,800 million (+15.4% YoY), and profit attributable to owners of parent of ¥3,100 million (+13.6% YoY).
Dividend forecast for FY2025 is 8.00 yen per share, up from 5.50 yen in FY2024.
FY2024 targets include a dividend payout ratio around 20% and SMR (solvency margin ratio) of 300–320%.
FY2030 vision includes ROE of 12–15% and transition to DOE (dividend on equity) disclosure.
Latest events from Anicom Holdings
- Double-digit profit and revenue growth driven by new policies and strong pet insurance demand.8715
Q3 202513 Jul 2026 - Record-high revenue and profit driven by pet insurance growth and investment gains, with lower profit forecasted.8715
Q4 202513 Jul 2026 - Revenue up 10.4% YoY, but profit down over 40% amid higher expenses and policy transfer costs.8715
Q1 202613 Jul 2026 - Double-digit recurring revenue and profit growth driven by robust pet insurance demand.8715
Q2 202513 Jul 2026 - Recurring revenue up 10.6% YoY, but profit fell on higher expenses and one-time costs.8715
Q3 202613 Jul 2026 - Recurring revenue up 10.6% YoY, but profit down 34.4% amid higher expenses and loss ratios.8715
Q2 202613 Jul 2026 - Recurring revenue up 9.1%, profit down 32.1%, with strong FY03/27 growth and higher dividends forecast.8715
Q4 202613 Jul 2026